Is Viking Therapeutics Stock Going to $50? Bulls and Bears
A wide-open weight-loss drug market has investors buzzing about Viking Therapeutics. This article breaks down the bul...
Explore which performs better: index funds or mutual funds, focusing on costs, tracking error, and long-term results for investors.
24,353 articlesA wide-open weight-loss drug market has investors buzzing about Viking Therapeutics. This article breaks down the bul...
XRP surged above key resistance as volume inflows and ETF demand point to renewed institutional interest. Regulators ...
Oracle faced a notable June pullback as its AI cloud strategy met mixed reactions. This article breaks down what happ...
Rivian remains valued far below Ford despite big hype around electric-vehicle startups. With Rivian’s deliveries risi...
The housing market just split into two distinct paths: rising prices in the Northeast and cooler markets on the West ...
Bloom Energy has climbed about 160% ytd, powered by a surge in AI-related data-center demand and new partnerships. Th...
As earnings season unfolds, Apogee faces a meaningful year ahead. This article breaks down Q1 signals, outlines a rea...
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Jim Cramer argues Meta's AI model shift delivered a roughly $100 per share move, illustrating why big tech remains ha...
U.S. stocks climbed on Tuesday as inflation cooled more than expected, helping the S&P 500 regain ground. Futures poi...
The Trump administration presses more to accelerate domestic memory fabrication, aiming to reduce reliance on oversea...
IREN stock fell sharply as investors reprice AI infrastructure bets after a month of steep declines. While the sector...